Loring Wolcott & Coolidge Fiduciary Advisors’s Rayonier RYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-330
Closed -$7K 585
2026
Q1
$7K Hold
330
﹤0.01% 530
2025
Q4
$7.62K Buy
+330
New +$7.46K ﹤0.01% 502
2017
Q4
Sell
-21
Closed 855
2017
Q3
$0 Buy
+21
New +$546 ﹤0.01% 885
2015
Q4
Sell
-4,414
Closed -$102K 670
2015
Q3
$102K Hold
4,414
﹤0.01% 353
2015
Q2
$102K Hold
4,414
﹤0.01% 353
2015
Q1
$108K Hold
4,414
﹤0.01% 356
2014
Q4
$112K Sell
4,414
-874
-17% -$23.4K ﹤0.01% 345
2014
Q3
$149K Buy
5,288
+874
+20% +$26.8K ﹤0.01% 303
2014
Q2
$142K Buy
+4,414
New +$138K ﹤0.01% 312

Other funds holding RYN

Loring Wolcott & Coolidge Fiduciary Advisors's RYN Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Rayonier (RYN) in Q2 2026, closing a stake of 330 shares — an estimated $7K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in RYN in Q2 2014 and held it in 9 quarters. The position peaked at $149K in Q3 2014. 223 funds tracked by Wall St. Rank hold RYN as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Rayonier position as of Q2 2026 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 330 Rayonier shares in Q2 2026, an estimated $7K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Rayonier in Q2 2014 and held it in 9 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Rayonier position peaked at $149K in Q3 2014.
  • 223 funds tracked by Wall St. Rank held Rayonier as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.